Here, we show CD44 cell surface receptor as a novel target molecule for RPE cells under oxidative stress, and validate the use of CD44 aptamer for lysosomal targeting in RPE cells to prevent AMD. This evidence concerns the gene CD177 and age-related macular degeneration.